Bioavailability of orally administered rhGM-CSF: a single-dose, randomized, open-label, two-period crossover trial.
BACKGROUND: Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) is usually administered by injection, and its oral administration in a clinical setting has been not yet reported. Here we demonstrate the bioavailability of orally administered rhGM-CSF in healthy volunteers....
Main Authors: | Wenping Zhang, Zhengbing Lv, Zuoming Nie, Guogang Chen, Jian Chen, Qing Sheng, Wei Yu, Yongfeng Jin, Xiangfu Wu, Yaozhou Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2677157?pdf=render |
Similar Items
-
Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim)
by: Marta E. Gajewska, et al.
Published: (2018-01-01) -
Studies on the expression of recombinant human granulocyte macrophage colony-stimulating factor(rhGM-CSF) in Aspergillus niger.
by: Chu Hung-Yi, et al.
Published: (2007) -
Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood
by: Mariana Aris, et al.
Published: (2019-09-01) -
G-CSF and GM-CSF : effects on neonatal neutrophils
by: Bailie, Karen Elizabeth Margaret
Published: (1993) -
Hight –efficient production of recombinant mGM-CSF
by: Young Chen Chen, et al.
Published: (2008)